<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Phio Pharmaceuticals Corp.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Phio Pharmaceuticals Corp.

    Phio Pharmaceuticals is focused on developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYLTM) therapeutic platform. Immunotherapies harness our immune system to restore surveillance of tumors that evade detection – a potential curative medicine. INTASYLTM therapeutics can be used as a standalone treatment or in combination with other modalities. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Dr. Gerrit Dispersyn
    • FOUNDED
      2011
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Restance, Inc.

    Restance, Inc.

    Restance is pursuing several business lines in the growing economies of East Afric...

    Restance is pursuing several business lines in ...

    Eidos Therapeutics, Inc.

    Eidos Therapeutics, Inc.

    Eidos is a clinical stage biopharmaceutical company focused on addressing the larg...

    Eidos is a clinical stage biopharmaceutical com...

    Filing Type:    PU
    InVivo Therapeutics Holdings Corp.

    InVivo Therapeutics Holdings Corp.

    Armed with cutting-edge technology and MIT science, experienced business and medic...

    Armed with cutting-edge technology and MIT scie...

    Filing Type:    PU
    Tricida, Inc.

    Tricida, Inc.

    Tricida, Inc. , Tricida, Inc. , is a pharmaceutical company focused on the develop...

    Tricida, Inc. , Tricida, Inc. , is a pharmaceut...

    Filing Type:    PU
    GENFIT S.A.

    GENFIT S.A.

    GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and de...

    GENFIT is a late-stage biopharmaceutical compan...

    Filing Type:    PU
    ARCA biopharma, Inc.

    ARCA biopharma, Inc.

    ARCA was founded on the belief that a precision medicine approach to drug developm...

    ARCA was founded on the belief that a precision...

    Filing Type:    PU
    Sorrento Therapeutics, Inc.

    Sorrento Therapeutics, Inc.

    Sorrento’s lead programs with short-term milestones consist of two clinical stag...

    Sorrento’s lead programs with short-term mile...

    Filing Type:    PU
    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    Trillium Therapeutics Inc.

    Trillium Therapeutics Inc.

    Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing ...

    Trillium Therapeutics Inc. is a clinical stage ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.